More on INO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+60.7% Growth)
- Ratings (5.6 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INO Income Statement

Click line-items for a historical chart and %
License fee and milestone revenue 2.33M
License fee and milestone revenue from affiliated entity 574.6K
Grant and miscellaneous revenue 9.41M
Total revenue 12.54M
Research and development 26.98M
General and administrative 5.76M
Gain on sale of assets
Total operating expenses 32.74M
Loss from operations -20.2M
Interest income, net
Other income, net
Loss from investment in affiliated entity -958.14K
Net loss -20.76M
Net loss/ (gain) attributable to non-controlling interest 0
Net loss attributable to Inovio Pharmaceuticals, Inc. -20.76M
Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders
Weighted average number of common shares outstanding - basic and diluted

Entities mentioned with INO

View All Entities